Category Archives: Strategy

Xofigo Approval Keeps the Ball Rolling For Bayer Oncology

US-based Bayer Healthcare Pharmaceuticals, as its executives were quick to point out, has now received three new approvals for cancer indications in the last eight months.
Posted in Strategy | Leave a comment

FDA: From Risk Aversion to Approval Activism

During the Rutgers Business School’s annual healthcare symposium, an FDA official encouraged industry to put its drugs on the reviewing table and be prepared for good news. On a panel titled “Activist FDA: Transformation Agent,” Prevision Policy founder and former Pink Sheet editorial head Cole Werble relayed the tale of Acadia Pharmaceuticals, a San Diego-based [...]
Also posted in Agency Insight, Biotech, FDA, Legal, Market Access, Orphan Drugs, People, R&D, Regulatory, leadership | Tagged , , , , , , , | 2 Comments

Congress 'Tip Toes' Around Obamacare

by Tom Norton Of the many issues involved with the actual implementation of the 2010 Affordable Care Act, aka, “Obamacare”, few are more intriguing to me than those that personally impact Members of Congress (MOCs).  Here’s a good example of what I’m talking about — Today, on Capitol Hill, MOCs, along with thousands of their personal [...]
Also posted in Guest Blog, Legal, healthcare | Tagged , , , , , , , , | 3 Comments

Ad Agency Encourages Pharma Marketers to Reboot

People tell you who they are, but we ignore it – because we want them to be who we want them to be. – Don Draper At the beginning of the Reboot Camp – held at New York City’s Alexandria Center on April 12 – Intouch Solutions’ CEO Faruk Capan declared the days of Don Draper [...]
Also posted in Advertising, Agency Insight, Emerging Markets, FDA, Marketing, Patient Communication, People, Regulatory, Sales, Technology, healthcare, leadership, patient education, social media | Tagged , , , , , , , , , , , , | 1 Comment

Physicians in ACOs Dare Pharma to Step up Its Game

Pharma, according to physicians currently embedded within Accountable Care Organizations (ACOs), is not living up to its potential. A survey conducted by Oliver Wyman has most of its 200 respondents saying the industry could play a more active role with value-based healthcare providers in helping to deliver better care at a lower cost, but it [...]
Also posted in healthcare | Tagged , , , , | Leave a comment